Portage Biotech Inc.
http://portagebiotech.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Portage Biotech Inc.
Finance Watch: J.P. Morgan Conference To Offer Glimpse Of 2024 Funding Forecast
Public Company Edition: Discussions at the J.P. Morgan Healthcare Conference 8-11 January in San Francisco should offer some insight on industry’s and investors’ expectations about the financial markets in 2024. The year started with some big financings, but also some new job cuts.
Scrip Asks...What Does 2023 Hold For Biopharma? Part 2: M&A And Partnering
Deal-making between big pharma and biotech looks set to rise with a looming patent cliff increasing the need for the former to replenish its pipelines. Meanwhile, biotechs need partners to help them advance amid the ongoing big freeze on raising cash on public markets.
Scrip Asks...What Does 2023 Hold For Biopharma? Part 1: The Funding Environment
With valuations down and borrowing costs up, many industry insiders are expecting Darwinian scenes in biotech this year. Survival of the fittest is the order of the day: companies with riskier, less commercially defined propositions will struggle, while platform companies with multiple shots on strong goals will increasingly find favor in a more risk-averse environment.
Portage Buys Tarus, Gaining Cancer Assets Targeting Immune Evasion
Acquisition valued at roughly $21m upfront for two clinical and two preclinical adenosine receptor antagonists.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Drug Discovery Technologies
- Large Molecule
-
Drug Discovery Technologies
- Genomics-Proteomics
- Other Names / Subsidiaries
-
- 3Legs Resources plc
- Biohaven Pharmaceutical Holding Company Ltd.
- Bontan Corporation, Inc.
- Intensity Holdings Limited
- Intensity Therapeutics, Inc.
- iOx Therapeutics, Ltd
- Oncomer
- Portage Acquisition Inc.
- Portage Pharmaceuticals Limited (PPL)
- JV Co
- Portage Glasgow Limited (PGL)
- Nekonal SARL
- SalvaRx Limited
- Saugatuck Therapeutics Ltd.
- Rift Biotherapeutics
- SalvaRx Group plc
- Tarus Therapeutics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice